Corrigendum to “Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma” [Eur Urol 2023] (European Urology, (S0302283823000015), (10.1016/j.eururo.2023.01.001))

Matthew S. Ernst, Vishal Navani, J. Connor Wells, Frede Donskov, Naveen Basappa, Chris Labaki, Sumanta K. Pal, Luis Meza, Lori A. Wood, D. Scott Ernst, Bernadett Szabados, Rana R. McKay, Francis Parnis, Cristina Suarez, Takeshi Yuasa, Aly Khan Lalani, Ajjai Alva, Georg A. Bjarnason, Toni K. Choueiri, Daniel Y.C. Heng

科研成果: 期刊稿件 › 评论/辩论 › 同行评审

1 引用（Scopus）

指纹

探究 'Corrigendum to “Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma” [Eur Urol 2023] (European Urology, (S0302283823000015), (10.1016/j.eururo.2023.01.001))' 的科研主题。它们共同构成独一无二的指纹。

Corrigendum to “Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma” [Eur Urol 2023] (European Urology, (S0302283823000015), (10.1016/j.eururo.2023.01.001))

指纹

Keyphrases

Medicine and Dentistry